Therapeutic Material Introduced Or Removed In Response To A Sensed Body Condition Patents (Class 604/503)
-
Publication number: 20130190717Abstract: A microplegia console for controlling the delivery of cardioplegia to a patient, comprising an integrated display/touch screen for displaying cardioplegia information and patient information and allowing inputting of parameters via the display/touch screen into the console for computer-controlled perfusion of cardioplegia into the patient. The invention further comprises a method for delivery of cardioplegia to a patient, including defining and selecting a protocol from a displayed list and sequencing a series of the protocols. The invention also comprises a method for cardioplegia delivery to achieve aortic valve closure. Additionally, the invention comprises a method for activating an icon whereby, upon a first selection of the icon, displaying an indicia indicating that the icon has been first selected; and upon a second selection of the icon, activating the icon.Type: ApplicationFiled: September 13, 2012Publication date: July 25, 2013Applicant: QUEST MEDICAL, INC.Inventors: Michael L. Dollar, Cristo Suresh Corera, Kenneth A. Jones
-
Patent number: 8491491Abstract: Inhalation measurement systems and methods enable, during inhalant exposure, substantially real-time respiratory measurements of a test subject using techniques that obtain measurements of respiration directly from that test subject, instead of from inhalation chamber parameter measurements. Direct test subject respiratory measurements may be, by way of example only, impedance measurements. These respiratory measurements taken directly from the test subject may be transmitted, wirelessly for example, for processing during the course of the test to a processing system to determine a cumulative volume of inhalant inspired by the test subject. From that, a cumulative amount of inhalant (or dose) inspired by the test subject may be determined during the course of the inhalation compound test.Type: GrantFiled: March 2, 2010Date of Patent: July 23, 2013Assignee: Data Sciences International, Inc.Inventors: Paul A. Haefner, Loell Boyce Moon, Steve Hachtman, Scott R. Tiesma, Gary Pritchard
-
Publication number: 20130178791Abstract: The present invention generally relates to radio-enabled devices for detection and remedy of biological and chemical warfare attack. More particularly, this invention relates to an on-body apparatus that provides a means of treatment which is innocuous to the wearer, but capable of injecting antidotes within seconds and preferably also combines multiple means of sensing chemical and biological agents as well as monitoring user's physiological response to the antidotes thereby to enable tailored and continuous infusion of antidotes while minimizing the side effect of the antidotes themselves. A key embodiment of this invention is the incorporation of an electronically-controlled needle or cannula that will deploy only when commanded to. When not deployed, the device sits inertly against the patient's skin, affixed by adhesive and or elastic materials.Type: ApplicationFiled: January 9, 2012Publication date: July 11, 2013Inventor: Jonathan C. Javitt
-
Patent number: 8480648Abstract: An automated therapy system having an infusion catheter; a sensor adapted to sense a patient parameter; and a controller communicating with the sensor and programmed to control flow output from the infusion catheter into a patient based on the patient parameter without removing fluid from the patient. The invention also includes a method of controlling infusion of a fluid to a patient. The method includes the following steps: monitoring a patient parameter with a sensor to generate a sensor signal; providing the sensor signal to a controller; and adjusting fluid flow to the patient based on the sensor signal without removing fluid from the patient.Type: GrantFiled: January 19, 2012Date of Patent: July 9, 2013Assignee: Velomedix, Inc.Inventors: Daniel Rogers Burnett, Gregory Hall, Christopher Hermanson, Amit Rajguru
-
Publication number: 20130172849Abstract: The present invention provides a system and method for controlling resuscitation in a patient. In at least one embodiment, the invention includes a fluid rate measurer, a controller electrically coupled to the fluid rate measurer, and a pump. The controller is adapted to receive signals from a physiological monitor and controls the pump.Type: ApplicationFiled: September 14, 2012Publication date: July 4, 2013Applicant: Government of the United States as represented by the Secretary of the ArmyInventors: Jill L. Sondeen, Guy A. Drew
-
Patent number: 8469942Abstract: A device for delivering fluid to a user includes a housing, a drive motor assembly in the housing, a force sensor, and an electronics module. The drive motor assembly regulates delivery of fluid by actuating a piston of a fluid reservoir, and the force sensor generates output levels in response to force imparted thereto during, for example, fluid delivery operations. The electronics module processes the output levels of the force sensor to assess the operating health of the force sensor, to check for occlusions in the fluid delivery path, and to monitor the seating status of the fluid reservoir.Type: GrantFiled: September 2, 2011Date of Patent: June 25, 2013Assignee: Medtronic Minimed, Inc.Inventors: Hsiao-Yu S. Kow, Afshin Bazargan, Ian B. Hanson, Pablo Vazquez, Juan M. Alderete, Jr., Salman Monirabbasi
-
Publication number: 20130158504Abstract: A system and method for monitoring and delivering medication to a patient includes a controller that has a control algorithm and a closed loop control that monitors the control algorithm. A sensor is in communication with the controller and monitors a medical condition. A rule base application in the controller receives data from the sensor and the closed loop control and compares the data to predetermined medical information to determine the risk of automation of therapy to the patient. The controller then provides a predetermined risk threshold where below the predetermined risk threshold automated closed loop medication therapy is provided. If the predetermined risk threshold is met or exceeded, automated therapy adjustments may not occur and user/clinician intervention is requested.Type: ApplicationFiled: December 14, 2012Publication date: June 20, 2013Inventors: Timothy L. Ruchti, Mohammad M. Khair
-
Publication number: 20130158394Abstract: Devices, systems and methods are disclosed for measurement and reduction or prevention of fluid movement in lactiferous ducts, detection of diseased conditions in the breasts, and treatments thereof. Such techniques, methods and devices are applicable to a variety of conditions including carcinomas.Type: ApplicationFiled: January 14, 2011Publication date: June 20, 2013Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Sylvia Hon, Anahitta Khosraviani, Amar Miglani, David Brandon Smith, Lanping Amy Sung, Geert W. Schmid-Schonbein
-
Patent number: 8465467Abstract: A dual pump aspiration system having both a vacuum level control loop and a flow rate control loop. The system can be operated either as a vacuum priority system or a flow rate priority system.Type: GrantFiled: September 14, 2006Date of Patent: June 18, 2013Assignee: Novartis AGInventor: Shawn X. Gao
-
Publication number: 20130150823Abstract: The invention relates to a method and apparatus for providing hydration fluids. The invention allows for a ‘background’ rate of providing a hydration fluid to be automatically supplied by an apparatus to a patient, for example intravenously, and for the patient to receive an extra amount of hydration fluid, or ‘bolus dose’, to be provided when the patient sends a signal to the apparatus. In preferred embodiments the background supply rate, the volume and rate of supply of the bolus dose and the maximum extra volume that can be provided as bolus doses in a given time can be set, for example, by a nurse.Type: ApplicationFiled: January 21, 2011Publication date: June 13, 2013Inventors: Hugh E. Montgomery, Michael Mythen, Anthony Thorne
-
Publication number: 20130150737Abstract: A method of detecting and treating a microvascular obstruction is provided. In one embodiment, a catheter is provided for both detecting the microvascular obstruction and treating or removing the obstruction.Type: ApplicationFiled: February 5, 2013Publication date: June 13, 2013Applicant: OSPREY MEDICAL, INC.Inventor: OSPREY MEDICAL, INC.
-
Publication number: 20130150824Abstract: Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.Type: ApplicationFiled: February 6, 2013Publication date: June 13, 2013Applicant: ASANTE SOLUTIONS, INC.Inventor: ASANTE SOLUTIONS, INC.
-
Publication number: 20130131468Abstract: A medical device for carrying out at least one medical function, comprising at least one element that can be at least partially inserted into a body tissue of a user and further comprising at least one housing that can be placed on a skin surface of the user. The housing has a multipart design and comprises at least one functional component. The functional component can be connected to the insertable element. The housing further comprises at least one protective component. The protective component is designed to at least partially enclose the functional component. The protective component can be connected to the functional component, particularly after insertion of the insertable element.Type: ApplicationFiled: January 11, 2013Publication date: May 23, 2013Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventor: Roche Diagnostics Operations, Inc.
-
Patent number: 8444623Abstract: A patient hydration method includes administering hydration fluid to a patient, and a hydration fluid measurement device responsible to a source of hydration fluid, a patient urine output measurement device. A controller is responsive to the hydration fluid measurement device and the patient urine output measurement device. The controller operates the infusion device, in response to the patient urine output measurement device and the hydration fluid measurement device, to hydrate the patient based on the patient's urine output.Type: GrantFiled: June 6, 2011Date of Patent: May 21, 2013Assignee: PLC Medical Systems, Inc.Inventors: Mark Gelfand, Howard R. Levin
-
Patent number: 8444622Abstract: A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes an enclosure including one or more sensors, a controller, and one or more applicators configured to surround one or more joints of articulating bone of a mammalian subject, wherein the one or more sensors are configured to detect one or more physiological conditions of the one or more joints of the mammalian subject, and the controller, configured to communicate with the one or more sensors, is configured to activate the one or more applicators, and wherein the one or more applicators are configured to inject one or more medicaments to one or more joint tissues of the mammalian subject.Type: GrantFiled: February 19, 2010Date of Patent: May 21, 2013Assignee: The Invention Science Fund I, LLCInventors: Philip A. Eckhoff, Roderick A. Hyde, Muriel Y. Ishikawa, Jordin T. Kare, Eric C. Leuthardt, Dennis J. Rivet, Elizabeth A. Sweeney, Lowell L. Wood, Jr., Victoria Y. H. Wood
-
Publication number: 20130123745Abstract: An infusion pump includes: a housing, a pump actuator supported by the housing, electronics configured to control the pump actuator, a pain controlled analgesic (“PCA”) input device, a cord having a remote end connected to the PCA input device and a local end connected to the housing, a remote integrated circuit; and a local integrated circuit in communication with the electronics and the remote integrated circuit so as to provide operational information concerning the PCA input device to the electronics.Type: ApplicationFiled: January 4, 2013Publication date: May 16, 2013Applicants: Baxter Healthcare S.A., Baxter International, Inc.Inventors: Baxter International Inc., Baxter Healthcare S.A.
-
Publication number: 20130096486Abstract: The invention relates to a system (1) for controlling an electrolytic reaction in a reaction medium, with the system (1) comprising a primary energy storage (10), an intermediate storage (30) and a control unit (50). The control unit of the system is adapted for transferring electrical energy from the primary energy storage into the intermediate storage, monitoring the state of charge of the intermediate storage, establishing an electric connection between the reaction medium and the intermediate storage when the state of charge of the intermediate storage is larger than or equal to a first threshold value, and interrupting an electric connection between the reaction medium and the intermediate storage when the state of charge of the intermediate storage is smaller than or equal to a second threshold value.Type: ApplicationFiled: March 2, 2011Publication date: April 18, 2013Applicant: ACINO AGInventors: Britta Schroeder, Thomas Roos, Thomas Beckert
-
Patent number: 8419707Abstract: A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes one or more substrates configured to contact one or more body contours in proximity to one or more joints of articulating bone of a mammalian subject; one or more sensors configured to detect one or more physiological conditions of the one or more joints; and one or more microjet applicators supported by the one or more substrates and configured to respond to the one or more sensors by injecting one or more medicaments to the one or more joint tissues of the mammalian subject.Type: GrantFiled: February 19, 2010Date of Patent: April 16, 2013Assignee: The Invention Science Fund I, LLCInventors: Philip A. Eckhoff, Roderick A. Hyde, Muriel Y. Ishikawa, Jordin T. Kare, Eric C. Leuthardt, Dennis J. Rivet, Elizabeth A. Sweeney, Lowell L. Wood, Jr., Victoria Y. H. Wood
-
Publication number: 20130085471Abstract: A system and method for monitoring at least one blood parameter of the blood of different patients, comprising a plurality of access devices for establishing at least one means of access to the blood of each patient through the skin, a plurality of removal devices for removing a quantity of blood from each patient in order to obtain at least one blood sample, at least one blood analysis device for analysing the blood sample with respect to predeterminable blood parameters and for generating individual blood parameter data sets, a calculation device which can be used jointly for a plurality of blood parameter data sets of different patients for calculating data sets of drug parameters of the drugs to be administered to the respective patient on the basis of the individual blood parameter data sets, and a plurality of supply devices for supplying the respective drug having the calculated drug parameters.Type: ApplicationFiled: March 3, 2011Publication date: April 4, 2013Inventors: Hans-Otto Maier, Torsten Doenhoff, Horst Schmoll, Matthias Paetzold
-
Publication number: 20130072755Abstract: A nasal delivery device can include a nasal prong and an activation member. The nasal prong can comprises an opening at a top and bottom portion of the prong to allow for the passage of an aerosolized treatment agent through the nasal prong. The activation member can be positioned on the nasal delivery device at a location that is spaced apart from the subject's oral cavity when the nasal prong is received into the nostril of the subject. The activation member can be configured to detect a desired exhalation state of the subject and upon detection of the desired exhalation state, the activation member activates the delivery of the aerosolized treatment agent.Type: ApplicationFiled: June 3, 2011Publication date: March 21, 2013Inventors: Mark J. Papania, James J. Barry, Mark C. Bagley, Eric M. Friets, Darin A. Knaus
-
Patent number: 8398577Abstract: A device for removing fluid from a first bodily cavity and for directing that fluid into a second bodily cavity while avoiding risks of infection and, in one embodiment, excessive dehydration of the first bodily cavity. The device includes an uptake tube having a proximal end in fluid communication with the first bodily cavity and a distal end in fluid communication with a pump, and an outflow tube having a proximal end in fluid communication with the pump and a distal end in fluid communication with the second bodily cavity. The distal end of the uptake tube may be coupled to a reservoir configured to expand upon ingression of fluid into the reservoir and to contract upon removal of fluid due to a negative pressure provided by the pump.Type: GrantFiled: October 31, 2007Date of Patent: March 19, 2013Assignee: Sequana Medical AGInventor: Daniel R. Burnett
-
Patent number: 8398609Abstract: During diastolic coronary perfusion, blood perfuses through the heart via the coronary arteries. Delivery of a therapeutic and/or diagnostic agent to the heart during diastolic coronary perfusion allows the therapeutic and/or diagnostic agent to efficiently perfuse through the heart. A medical device according to the invention detects closure of the aortic valve of a heart, and initiates delivery of a therapeutic and/or diagnostic agent upon detection of aortic valve closure. The medical device detects aortic valve closure by processing a signal. Exemplary signals used by the medical device to detect aortic valve closure include left or right ventricular accelerometer signals, left or right ventricular flow signals, left or right ventricular pressure signals, aortic pressure signals, pulse pressure signals, systemic arterial pressure signals, electrogram signals, and phonocardiogram signals.Type: GrantFiled: May 25, 2011Date of Patent: March 19, 2013Assignee: Medtronic, Inc.Inventor: Edward Chinchoy
-
Publication number: 20130060228Abstract: The invention relates to a secure system for the perfusion of a body liquid, enabling a final control of compatability of a treatment with the patient and/or the medical situation previously diagnosed by a doctor, in a simple, efficient and energy-saving manner.Type: ApplicationFiled: October 29, 2010Publication date: March 7, 2013Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ETABLISSEMENT FRANCAIS DU SANG, UNIVERSITE DE FRANCHE-COMTE, CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCONInventors: Lionel Pazart, Bruno François Marcel Wacogne, Christian Gérard Daniel Pieralli, Wilfrid Hervé Boireau, Pascal Charles Serge Morel
-
Patent number: 8388598Abstract: The invention concerns a method and device for controlling a number of infusion pumps 2-10, whereby each infusion pump (2-10) has an infusate assigned to it which is administered within a pre-determinable period of time assigned to it as an infusion at a pre-determinable infusion rate to a living being, whereby the infusion pumps (2-10) exchange control data for activating and deactivating the various infusions in a chronologically coordinated manner autonomously.Type: GrantFiled: May 11, 2006Date of Patent: March 5, 2013Assignee: B. Bruan Medizinelektronik GmbH & Co. KGInventor: Alexander Steinkogler
-
Publication number: 20130053820Abstract: Some embodiments of a wearable infusion pump system can include a pump device having a drive system to dispense a medicine to a user, an activity sensor that detects a possible change in an activity level of the user, and a controller to activate the drive system to dispense the medicine to the user. The controller device can query the user to indicate whether a detected activity level of the user represents an actual change in the activity level of the user. The controller device can alter the medicine dispensing schedule based on the user indicated changes in activity level.Type: ApplicationFiled: September 14, 2012Publication date: February 28, 2013Applicant: ASANTE SOLUTIONS, INC.Inventors: Mark C. Estes, Deb Ruppert
-
Publication number: 20130046281Abstract: A closed loop infusion formulation delivery system for controlling a biological state in the body of a user includes a sensor for generating a signal representative of measured parameters and a computing element for processing the generated signal. The computing element adjusts control parameters within an algorithm, calculates a delivery rate of an infusion formulation and generates commands based on the calculated delivery rate. A remotely located monitoring station communicates with the computing element via radio or wire to further adjust the control parameters within the algorithm to meet changing needs in the body of the user.Type: ApplicationFiled: August 17, 2011Publication date: February 21, 2013Inventor: Jonathan C. Javitt
-
Publication number: 20130046279Abstract: A medical system includes a monitoring unit and a drug delivery unit. The monitoring unit is operable to monitor at least one physiological parameter of a patient. The drug delivery unit includes an integral volume of a drug. A control logic is in communication with the monitoring unit and the drug delivery unit and is operable to regulate delivery of the drug to the patient from the integral volume, based on data associated with the at least one physiological parameter of the patient, in accordance with a safety shell control algorithm. A user interface feature is operable to receive input indicating administration of an external drug to the patient. The safety shell control algorithm responds to inputs received through the user interface feature indicating administration of an external drug to the patient, such as by modifying subsequent drug delivery regulation based on the administration of the external drug.Type: ApplicationFiled: August 16, 2011Publication date: February 21, 2013Inventors: Paul J. Niklewski, James F. Martin, Donn C. Mueller, David Q. Feng, Ross G. Krogh, Hemant Jampala
-
Publication number: 20130045467Abstract: A medical device is disclosed. The medical device includes an RFID reader for receiving information from at least one RFID transponder. The medical device also includes a memory for storing a database and at least one processor for processing information. Also, a remote controller for a medical device is disclosed. The remote controller includes an information receiver for receiving information related to food. The infusion device also includes a memory for storing a database and at least one processor for processing information. A method for use in a medical device is also disclosed. The method includes receiving information from an RFID transponder related to food. Also, the processing the information by comparing the information to a database is included in the method. The method also includes determining the acceptability of the food and providing information related to acceptability to the user.Type: ApplicationFiled: October 22, 2012Publication date: February 21, 2013Applicant: DEKA Products Limited PartnershipInventor: DEKA Products Limited Partnership
-
Publication number: 20130046280Abstract: A medical system includes a monitoring unit and a drug delivery unit. The monitoring unit is operable to monitor at least one physiological parameter of a patient. The drug delivery unit includes an integral volume of a drug. A control logic is in communication with the monitoring unit and is operable to regulate delivery of the drug to the patient from the integral volume, based on data associated with the at least one physiological parameter of the patient, in accordance with a safety shell control algorithm. A user interface feature is operable to receive input indicating a stage of progress in a medical procedure. The safety shell control algorithm responds to inputs received through the user interface feature indicating a stage of progress in a medical procedure, such as by modifying subsequent drug delivery regulation based on the beginning or completion of a stage of progress in a medical procedure.Type: ApplicationFiled: August 16, 2011Publication date: February 21, 2013Inventors: James F. Martin, Paul J. Niklewski, Jeffery A. Foster
-
Patent number: 8373557Abstract: A wireless network having an architecture that resembles a peer-to-peer network has two types of nodes, a first sender type node and a second receiver/relay type node. The network may be used in a medical instrumentation environment whereby the first type node may be wireless devices that could monitor physical parameters of a patient such as for example wireless oximeters. The second type node are mobile wireless communicators that are adapted to receive the data from the wireless devices if they are within the transmission range of the wireless devices. After an aggregation process involving the received data, each of the node communicators broadcasts or disseminates its most up to date data onto the network. Any other relay communicator node in the network that is within the broadcast range of a broadcasting communicator node would receive the up to date data.Type: GrantFiled: October 19, 2007Date of Patent: February 12, 2013Assignee: Smiths Medical ASD, Inc.Inventors: Guy Smith, Matthew T. Oswald, Matthew L. Brown, Matthew E. Ellis
-
Publication number: 20130018298Abstract: The present invention relates generally to iontophoretic drug delivery systems for transdermal delivery of therapeutic agents and, more particularly, to packaging such systems for long shelf life and easy assembly for use. The system package includes an iontophoretic skin worn patch component that accommodates a power source, electronics, electrodes and a drug pack component that carries a therapeutic agent which is contained as a separate sealed component. The packaged system further provides for ease of assembly at the time of use.Type: ApplicationFiled: September 20, 2012Publication date: January 17, 2013Applicant: TEIKOKU PHARMA USA, INC.Inventor: Teikoku Pharma USA, Inc.
-
Patent number: 8353896Abstract: Embodiments of devices and system for controllable nasal delivery of materials are described. Methods of use of such devices and system and software for controlling the operation of such devices and systems are also disclosed.Type: GrantFiled: May 4, 2006Date of Patent: January 15, 2013Assignee: The Invention Science Fund I, LLCInventors: W. Daniel Hillis, Roderick A. Hyde, Muriel Y. Ishikawa, Elizabeth A. Sweeney, Clarence T. Tegreene, Richa Wilson, Lowell L. Wood, Jr., Victoria Y. H. Wood
-
Patent number: 8343092Abstract: Method and system for integrating infusion device and analyte monitoring system including medication infusion device such as an insulin pump and an analyte monitoring system such as a glucose monitoring system are provided.Type: GrantFiled: November 24, 2009Date of Patent: January 1, 2013Assignee: Abbott Diabetes Care Inc.Inventors: Benjamin M. Rush, Christopher V. Reggiardo
-
Publication number: 20120330274Abstract: Devices, systems, or methods are disclosed herein for treatment of disease in a vertebrate subject. The device can include a quasi-planar substrate; and one or more laterally-mobile effector molecule types at least partially embedded within the quasi-planar substrate, wherein the one or more laterally-mobile effector molecule types is configured to interact with one or more cell types. The device can further include one or more sensors configured to detect at least one aspect of an interaction between the at least one of the one or more laterally-mobile effector molecule types and the one or more cell types; and a controller in communication with the one or more sensors, wherein the controller is configured to responsively initiate modification of at least one of the one or more laterally-mobile effector molecule types, the quasi-planar substrate, and the one or more cell types.Type: ApplicationFiled: September 23, 2011Publication date: December 27, 2012Inventors: Roderick A. Hyde, Lowell L. Wood, JR.
-
Publication number: 20120330117Abstract: Tools and techniques for estimating a probability that a patient is bleeding or has sustained intravascular volume loss (e.g., due to hemodialysis or dehydration) and/or to estimate a patient's current hemodynamic reserve index, track the patient's hemodynamic reserve index over time, and/or predict a patient's hemodynamic reserve index in the future. Tools and techniques for estimating and/or predicting a patient's dehydration state. Tools and techniques for controlling a hemodialysis machine based on the patient's estimated and/or predicted hemodynamic reserve index.Type: ApplicationFiled: July 20, 2012Publication date: December 27, 2012Applicants: The Regents of the University of Colorado, a body corporate, Flashback Technologies, Inc.Inventors: Gregory Zlatko Grudic, Steven Lee Moulton, Isobel Jane Mulligan
-
Publication number: 20120323215Abstract: The invention relates to a system and a method for administering medicaments to a patient, comprising: at least a first measuring device (7, 8) for measuring urine values of the urine of a patient (2); at least a first evaluation device (6) for evaluating the measured urine values (6a); at least a first calculating device (13) for calculating first medicament parameters of the medicaments to be administered to the respective patient (2) on the basis of the evaluated, measured urine values (6a); and at least one delivery device (1) for delivering the respective medicaments with calculated, common medicament parameters.Type: ApplicationFiled: March 3, 2011Publication date: December 20, 2012Inventors: Hans-Otto Maier, Horst Schmoll, Matthias Paetzold
-
Patent number: 8330596Abstract: Provided is a sensor node including: a sensor for measuring biological information; a CPU for acquiring data by driving the sensor; a wireless communication unit for transmitting the data acquired by the CPU; a battery for supplying the control unit, the wireless communication unit, and the sensor with electric power; a RAM for storing the data; a compression unit for compressing the data stored in the RAM when the wireless communication unit cannot carry out the transmission; and a flash memory for storing the compressed data, thereby storing as much sensing data as possible on the sensor node, which is limited in resources, and preventing loss of the sensing data.Type: GrantFiled: June 4, 2008Date of Patent: December 11, 2012Assignee: Hitachi, Ltd.Inventors: Takeshi Tanaka, Shunzo Yamashita, Kiyoshi Aiki
-
Patent number: 8328754Abstract: Some embodiments of a wearable infusion pump system can include a pump device having a drive system to dispense a medicine to a user, an activity sensor that detects a possible change in an activity level of the user, and a controller to activate the drive system to dispense the medicine to the user. The controller device can query the user to indicate whether a detected activity level of the user represents an actual change in the activity level of the user. The controller device can alter the medicine dispensing schedule based on the user indicated changes in activity level.Type: GrantFiled: February 11, 2011Date of Patent: December 11, 2012Assignee: Asante Solutions, Inc.Inventors: Mark C. Estes, Deb Ruppert
-
Publication number: 20120302991Abstract: This document discusses, among other things, an apparatus comprising a pump configured to deliver a fluid, a wireless communication port, a controller, and a housing to enclose the apparatus. The controller is configured to communicate with a second device via the communication port using an open standard wireless communication protocol. The housing includes a mechanical coupling to slidably engage the second device which includes a second wireless communication port. Slidably engaging the second device positions the first and second communication ports opposite each other to allow communication via the first and second communication ports when slidably engaged.Type: ApplicationFiled: May 29, 2012Publication date: November 29, 2012Inventors: Michael Blomquist, Timothy Bresina, William Van Dyke, Gail Beth Bynum, Michael Welsch
-
Publication number: 20120302990Abstract: A core apparatus connectable to at least one sensor and to at least one fluid delivery device which includes a base housing, a connection hub to couple to the at least one sensor and to the at least one fluid delivery device, and a controller disposed within the base housing to communicate with the at least one sensor and to the at least one fluid delivery device, wherein the controller forms a continuous feedback loop with the at least one sensor and the at least one fluid delivery device.Type: ApplicationFiled: March 29, 2012Publication date: November 29, 2012Inventor: Guilherme Jose Enne de Paula
-
Publication number: 20120296259Abstract: Embodiments provide apparatus and methods for delivering solid form medications such as pellets to various locations in the body. One embodiment provides an apparatus for in vivo delivery of medication pellets comprising a first chamber including an opening; a second chamber substantially surrounding the first chamber, a carriage disposed in the first chamber, a mechanism for transferring the medication pellets from the first chamber to the second chamber and a pusher plate. The carriage can hold and dispense a plurality of medication pellets. Each pellet contains a selected dose of drug to treat a medical condition. A catheter is positioned in the second chamber. The catheter has a lumen sized for the pellet, a proximal end inside the chamber and a distal end extending through chamber opening to deliver the pellet to a delivery site. The pusher plate engages and advances the pellet though the catheter to the delivery site.Type: ApplicationFiled: March 22, 2010Publication date: November 22, 2012Inventor: Mir Imran
-
Patent number: 8308673Abstract: Methods and devices for selectively removing an agent from a physiological site, e.g., a physiological efferent fluid collection site, are provided. Aspects of the invention include fluid removal (e.g., aspiration) devices having a fluid removal element and a flow modulator positioned at a distal end of the fluid removal element. The flow modulator is configured to converge intersecting fluid flow paths into the fluid removal element. Also provided are systems and kits for performing the subject methods. The subject invention finds use in a variety of different applications, including the selective removal of both therapeutic and diagnostic agents from a variety of different physiological sites.Type: GrantFiled: June 12, 2008Date of Patent: November 13, 2012Assignee: Catharos Medical Systems, Inc.Inventors: Ali Hassan, Lester John Lloyd, Michael Orth, Mark Yang, Binh Luong, Brian K. Courtney, Peter J. Fitzgerald
-
Patent number: 8311620Abstract: The invention provides a cardiac rhythm management system which includes a tachyarrhythmia detection and classification circuit programmed to detect and classify a tachyarrhythmia, a biologic therapy delivery device configured to deliver or regulate an expression cassette suitable for terminating or preventing atrial fibrillation (AF), and a control circuit coupled to the tachyarrhythmia detection and classification circuit and the biologic therapy delivery device. Also provided is an implantable medical device for use in a body having a cardiovascular system, which includes an implantable device body including at least a cardiovascular portion configured to be in the cardiovascular system, and an expression cassette incorporated into the cardiovascular portion of the implantable device body, the expression cassette selected to express a gene product that terminates or prevents AF. Further provided are methods which employ particular expression cassettes to prevent, inhibit or treat AF.Type: GrantFiled: August 22, 2007Date of Patent: November 13, 2012Assignee: Cardiac Pacemakers, Inc.Inventors: Jihong Qu, Haris J. Sih, Mark Schwartz, Prashant Sinha
-
Publication number: 20120277604Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.Type: ApplicationFiled: March 20, 2012Publication date: November 1, 2012Inventors: Martin Gerber, John Burnes, SuPing Lyu, VenKatesh R. Manda, Byant Pudil
-
Publication number: 20120277650Abstract: A method includes initiating a blood fluid removal session for a patient in need thereof; monitoring a cardiovascular parameter of the patient; determining whether the indicator of the cardiovascular state crosses a predetermined threshold; and altering a parameter of the blood fluid removal session if the indicator is determined have crossed the threshold.Type: ApplicationFiled: March 20, 2012Publication date: November 1, 2012Inventors: Martin Gerber, John Burnes, SuPing Lyu, VenKatesh R. Manda, Bryant Pudil
-
Publication number: 20120277552Abstract: Methods include monitoring blood pH or electrolyte levels and setting initial fluid parameters, such as dialysate fluid parameters or replacement fluid parameters, for a blood fluid removal session based the monitored data. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.Type: ApplicationFiled: March 20, 2012Publication date: November 1, 2012Inventors: Martin Gerber, SuPing Lyu, Bryant Pudil
-
Publication number: 20120277546Abstract: A medical monitoring device for monitoring electrical signals from the body of a subject is described. The medical monitoring device monitors electrical signals originating from a cardiac cycle of the subject and associates each cardiac cycle with a time index. The medical monitoring device applies a forward computational procedure to generate a risk score indicative of hyperkalemia, hypokalemia or arrhythmia of the subject. The medical monitoring device can adjust the forward computational procedure based upon clinical data obtained from the subject.Type: ApplicationFiled: April 19, 2012Publication date: November 1, 2012Applicant: MEDTRONIC, INC.Inventors: Orhan Soykan, VenKatesh R. Manda, Martin T. Gerber, Christopher M. Hobot
-
Publication number: 20120277551Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patent parameters. By comparing the patient's current parameters to past parameters in response to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.Type: ApplicationFiled: March 20, 2012Publication date: November 1, 2012Inventors: Martin Gerber, SyPing Lyu, Bryant Pudil
-
Publication number: 20120277655Abstract: A method includes initiating a blood fluid removal session of a patient; monitoring an indicator of tissue fluid volume of the patient, or a portion thereof, during the blood fluid removal session; monitoring an indicator of blood fluid volume of the patient during the blood fluid removal session; determining whether a ratio of the indicator of tissue fluid volume to indicator of blood fluid volume is outside of a predetermined range; and altering the rate of fluid removal during the blood fluid removal session if the ratio is determined to be outside of the predetermined range. A blood fluid removal system may be configured to carry out the method.Type: ApplicationFiled: March 20, 2012Publication date: November 1, 2012Inventors: Martin Gerber, John Burnes, SuPing Lyu, VenKalesh R. Manda, Bryant Pudil
-
Publication number: 20120277722Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.Type: ApplicationFiled: March 20, 2012Publication date: November 1, 2012Inventors: Martin Gerber, John Burnes, SuPing Lyu, VenKatesh R. Manda, Bryant Pudil